12량체 TRAIL 및 HSV-TK 자살유전자를 동시에 발현하는 벡터 및 이를 이용한 항암 줄기세포 치료제
    2.
    发明申请
    12량체 TRAIL 및 HSV-TK 자살유전자를 동시에 발현하는 벡터 및 이를 이용한 항암 줄기세포 치료제 审中-公开
    载体同时表达多克隆TRAIL和HSV-TK杀菌剂基因,以及使用相同抗原的干细胞治疗剂

    公开(公告)号:WO2013115608A1

    公开(公告)日:2013-08-08

    申请号:PCT/KR2013/000849

    申请日:2013-02-01

    Abstract: 본 발명은 12량체 TRAIL을 암호화하는 핵산서열 및 자살유전자 핵산서열을 포함하는 DNA 카세트, 상기 DNA 카세트를 포함하는 재조합 발현벡터, 상기 재조합 발현벡터를 이용하여 제조된 재조합 아데노바이러스, 상기 재조합 아데노바이러스로 형질감염된 숙주세포, 상기 숙주세포를 포함하는 암 치료용 조성물, 및 상기 암 치료용 조성물을 개체에 투여하는 단계를 포함하는 암 치료 방법에 관한 것이다. 본 발명의 DNA 카세트가 도입되어 12량체 TRAIL 및 HSV-TK를 동시에 생산하는 줄기세포 치료제는 기존 치료제에 비하여 항암 효과가 보다 우수하므로, 다양한 고형암 및 전이암 치료에 효과적으로 이용할 수 있다.

    Abstract translation: 本发明涉及:包含编码十二聚体TRAIL和自杀基因核酸序列的核酸序列的DNA盒; 包含DNA盒的重组表达载体; 使用重组表达载体制备的重组腺病毒; 通过重组腺病毒转染的宿主细胞; 用于治疗癌症的组合物,其包含所述宿主细胞; 以及癌症治疗方法,其包括向个体施用治疗癌症的组合物的步骤。 通过引入本发明的DNA盒同时产生十二聚体TRAIL和HSV-TK的干细胞治疗剂与现有治疗剂相比具有优异的抗癌作用,因此可有效地用于治疗各种固体 癌症和转移性癌症。

    냉장고 도어 가드의 조립 구조체
    5.
    发明授权
    냉장고 도어 가드의 조립 구조체 有权
    装配车门结构

    公开(公告)号:KR101132749B1

    公开(公告)日:2012-04-06

    申请号:KR1020090050203

    申请日:2009-06-08

    Abstract: PURPOSE: A refrigerator door guard assembly structure, capable of convenient attachment and detachment, is provided to efficiently and conveniently attach and detach a door guard by supplying the visual information about the assembly spot of the door guard. CONSTITUTION: A refrigerator door guard assembly structure(300) comprises an assemblage groove and an assembling protrusion(320a). The assemblage groove is formed in the inner surface of both sides of the refrigerator door. The upper side of the assemblage groove is formed in an arc shape. The assembling protrusion is formed on the outer side of the door guard. The assembling protrusion comprises a vertical face formed on a curved face.

    신규한 히알루론산 기반 하이드로겔 및 이의 용도
    6.
    发明公开
    신규한 히알루론산 기반 하이드로겔 및 이의 용도 有权
    基于羟丙酸的新型氢化物及其用途

    公开(公告)号:KR1020140090287A

    公开(公告)日:2014-07-17

    申请号:KR1020120145758

    申请日:2012-12-13

    CPC classification number: A61K31/728 A61K9/06 A61K31/203 A61K31/573

    Abstract: The present invention relates to hyaluronic acid-based hydrogel including a cell differentiating agent or a cell activity inducing material and produced using cucurbituril and polyamine, a cell treatment-assisting composition including the hydrogel, a cell treating composition including the hydrogel including a cell differentiating agent or a cell activity inducing material and mesenchymal stem cells, and a cell treatment-assisting composition including the hyaluronic acid-based hydrogel produced using cucurbituril and polyamine. Another purpose of the present invention relates to a cell treatment composition including the hydrogel and mesenchymal stem cells. The hyaluronic acid-based hydrogel provided in the present invention plays a role as a supplementary material for supporting stem cells which expresses a treatment material used as a cell treatment agent so as to promote the secretion of the treatment material and increase cell survival rates, so that the treatment effects of the cell treatment agent can be maximized. Accordingly, the hyaluronic acid-based hydrogel can be widely used to develop a cell treatment agent which exhibits improved effects.

    Abstract translation: 本发明涉及包含细胞分化剂或细胞活性诱导材料并使用葫芦巴和多胺制备的透明质酸系水凝胶,包含该水凝胶的细胞治疗辅助组合物,包含水凝胶的细胞处理组合物,其包含细胞分化剂 或细胞活性诱导材料和间充质干细胞,以及包含使用葫芦巴和多胺制备的透明质酸类水凝胶的细胞治疗辅助组合物。 本发明的另一个目的涉及包含水凝胶和间充质干细胞的细胞处理组合物。 本发明中提供的透明质酸水凝胶作为支持干细胞的辅助材料起作用,其表达用作细胞处理剂的处理材料,以促进处理材料的分泌并增加细胞存活率,因此 可以使细胞处理剂的处理效果最大化。 因此,透明质酸系水凝胶可广泛用于开发显示改善效果的细胞处理剂。

    자기조립 블록 공중합체를 이용한 나노 구조물 제조방법
    7.
    发明公开
    자기조립 블록 공중합체를 이용한 나노 구조물 제조방법 无效
    使用自组装块状共聚物制备纳米结构

    公开(公告)号:KR1020090087353A

    公开(公告)日:2009-08-17

    申请号:KR1020080012745

    申请日:2008-02-12

    CPC classification number: B82B3/0038 B82Y40/00 C08J5/005

    Abstract: A manufacturing method of a nano structure using self-assembled block copolymer is provided to easily form a nano structure on a metal surface. A manufacturing method of a nano structure using self-assembled block copolymer comprises the following steps: a step for forming a metal thin film on a substrate(a); a step for treating a surface of the metal thin film using oxygen plasma(b); a step for neutralizing the surface of the metal thin film(c); a step for coating a block copolymer on the surface(d); and a step for forming a self-assembled nano structure by annealing and exposing the block copolymer(e).

    Abstract translation: 提供使用自组装嵌段共聚物的纳米结构的制造方法,以容易地在金属表面上形成纳米结构。 使用自组装嵌段共聚物的纳米结构体的制造方法包括以下步骤:在基板(a)上形成金属薄膜的工序。 使用氧等离子体(b)处理金属薄膜的表面的步骤; 中和金属薄膜(c)的表面的步骤; 在表面(d)上涂布嵌段共聚物的步骤; 以及通过退火和暴露嵌段共聚物(e)形成自组装纳米结构的步骤。

    12량체 TRAIL 및 HSV-TK 자살유전자를 동시에 발현하는 벡터 및 이를 이용한 항암 줄기세포 치료제
    9.
    发明公开
    12량체 TRAIL 및 HSV-TK 자살유전자를 동시에 발현하는 벡터 및 이를 이용한 항암 줄기세포 치료제 审中-实审
    载体共转染多克隆TRAIL和SUICIDE基因HSV-TK及其使用的抗原干细胞药物

    公开(公告)号:KR1020130089214A

    公开(公告)日:2013-08-09

    申请号:KR1020130012051

    申请日:2013-02-01

    Abstract: PURPOSE: An anticancer stem cell medicine is provided to have an excellent anticancer effect compared with the existing drug, thereby being used effectively for treatment of various solid cancers and metastatic cancers. CONSTITUTION: A DNA cassette includes the respective nucleic acid sequence for coding dodecameric TRAIL (TNF related apoptosis inducing ligand) and suicide gene. A recombinant expression vector comprises the DNA cassette. The recombinant expression vector is derived from adenovirus. The recombinant adenovirus is made by the recombinant expression vector. The host cell is transfected with the recombinant adenovirus. The anticancer medicine contains the host cell. [Reference numerals] (AA) Survival rate after repeated MSC/dTRAIL-TK injection; (BB) Survival rate (%); (CC) Period (Day) after injecting tumor

    Abstract translation: 目的:提供抗癌干细胞药物与现有药物相比具有优异的抗癌作用,从而有效地用于治疗各种固体癌症和转移性癌症。 构成:DNA盒包括用于编码十二聚体TRAIL(TNF相关凋亡诱导配体)和自杀基因的各自的核酸序列。 重组表达载体包含DNA盒。 重组表达载体来源于腺病毒。 重组腺病毒由重组表达载体制备。 宿主细胞用重组腺病毒转染。 抗癌药含有宿主细胞。 (附图标记)(AA)重复MSC / dTRAIL-TK注射后的存活率; (BB)生存率(%); (CC)注射肿瘤后的时间(天)

    신규한 히알루론산 기반 하이드로겔 및 이의 용도
    10.
    发明授权
    신규한 히알루론산 기반 하이드로겔 및 이의 용도 有权
    基于透明质酸的新型水凝胶及其用途

    公开(公告)号:KR101605528B1

    公开(公告)日:2016-03-23

    申请号:KR1020120145758

    申请日:2012-12-13

    Abstract: 본발명은세포분화제또는세포활성유도물질을포함하고, 쿠커비투릴과폴리아민을이용하여제조된히알루론산기반하이드로겔, 상기하이드로겔을포함하는세포치료보조용조성물, 상기세포분화제또는세포활성유도물질을포함하는하이드로겔과중간엽줄기세포를포함하는세포치료용조성물, 쿠커비투릴과폴리아민을이용하여제조된히알루론산기반하이드로겔을포함하는세포치료보조용조성물및 본발명의또 다른목적은상기하이드로겔과중간엽줄기세포를포함하는세포치료용조성물에관한것이다. 본발명에서제공하는히알루론산기반하이드로겔은세포치료제로서사용되는치료물질을발현시키는줄기세포를지지하는보조제로서의역할을수행하여, 상기치료물질의분비를촉진시키고, 세포생존율을증가시켜서세포치료제의치료효과를극대화시킬수 있으므로, 보다향상된효능을나타내는세포치료제의개발에널리활용될수 있을것이다.

Patent Agency Ranking